Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 4Unknown 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Gastrointestinal Neoplasms 1

Interventions

Oxaliplatin 81S 1 (combination) 55Capecitabine 44apatinib 32Paclitaxel 32Docetaxel 32Irinotecan 27Fluorouracil 22Drug Therapy 21sintilimab 20Cisplatin 20Leucovorin 16Hyperthermic Intraperitoneal Chemotherapy 13XELOX 12Surgical Procedures, Operative 12camrelizumab 10Trastuzumab 10titanium silicide 9Tegafur 9Nivolumab 9Neoadjuvant Therapy 9pembrolizumab 8Laparoscopy 8Gastrectomy 8Folfox protocol 7Chemotherapy, Adjuvant 7toripalimab 6tislelizumab 6Ramucirumab 6Gastroscopy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Stomach Neoplasms × tegafur-gimeracil-oteracil × Clear all
NCT05396326 2022-05-31

A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Shanghai Zhongshan Hospital

Phase 1 Unknown
20 enrolled
Gastrointestinal

Stomach Neoplasms

NCT05346874 2022-05-26

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Shanghai Zhongshan Hospital

Phase 2 Unknown
37 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡